Literature DB >> 2742171

Comparison of viscoelastic measures of coagulation after cardiopulmonary bypass.

K J Tuman1, B D Spiess, R J McCarthy, A D Ivankovich.   

Abstract

Postoperative hemorrhage remains a major cause of morbidity after cardiopulmonary bypass (CPB). Treatment remains empiric because of the need for immediate correction and the lack of availability of rapid intraoperative coagulation monitoring (except for ACT) at most institutions. Thrombelastography (TEG) and Sonoclot analysis (SCT) are measures of viscoelastic properties of blood which allow rapid intraoperative evaluation of coagulation factor and platelet activity as well as overall clot integrity from a single blood sample. Routine coagulation tests (RCT) including activated clotting time (ACT), prothrombin time (PT), partial thromboplastin time (PTT), fibrinogen level (FIB), and platelet count (PLT) were determined and compared to TEG and SCT to assess which best predicted clinical hemostasis after CPB. Forty-two patients prospectively felt to be at high risk for excessive post-CPB bleeding had blood obtained for RCT, TEG, and SCT analysis before systemic heparinization and 30 min after protamine administration. Nine of 42 patients had excessive chest tube drainage, but no reoperations were required. After CPB, mean values for RCT were normal, but there were abnormalities in TEG and SCT parameters that reflect platelet-fibrin interaction. Both TEG and SCT were 100% accurate in predicting bleeding in these nine patients and, overall, both tests were significantly better predictors of postoperative hemorrhage than RCT. We conclude that viscoelastic determinants of clot strength may be abnormal after CPB and that SCT and TEG are, therefore, more useful than RCT for the detection and management of coagulation defects associated with CPB.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2742171

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  17 in total

1.  Analysis of the information content in Sonoclot data and reconstruction of coagulation test variables.

Authors:  Jan John Liszka-Hackzell; Gustaf Ekback
Journal:  J Med Syst       Date:  2002-02       Impact factor: 4.460

2.  Impairment of coagulation by commonly used resuscitation fluids in human volunteers.

Authors:  T J Coats; E Brazil; M Heron; P K MacCallum
Journal:  Emerg Med J       Date:  2006-11       Impact factor: 2.740

3.  The effects of commonly used resuscitation fluids on whole blood coagulation.

Authors:  T J Coats; E Brazil; M Heron
Journal:  Emerg Med J       Date:  2006-07       Impact factor: 2.740

Review 4.  Coagulation abnormalities in the trauma patient: the role of point-of-care thromboelastography.

Authors:  Eduardo Gonzalez; Fredric M Pieracci; Ernest E Moore; Jeffry L Kashuk
Journal:  Semin Thromb Hemost       Date:  2010-10-26       Impact factor: 4.180

5.  Template for rapid analysis of the Sonoclot Signature.

Authors:  M A Lyew; W C Spaulding
Journal:  J Clin Monit       Date:  1997-07

6.  Thromboelastography and peripartum coagulation profiles associated with caesarean section delivery.

Authors:  R Smith; T Campbell-Owen; H Maybury; S Pavord; J Waugh
Journal:  Obstet Med       Date:  2009-09-01

Review 7.  Management of Trauma-Induced Coagulopathy with Thrombelastography.

Authors:  Eduardo Gonzalez; Ernest E Moore; Hunter B Moore
Journal:  Crit Care Clin       Date:  2017-01       Impact factor: 3.598

8.  Effect of delay and storage on whole-blood clotting analysis as determined by thrombelastography.

Authors:  C E Orlikowski; W B Murray; D A Rocke
Journal:  J Clin Monit       Date:  1993-01

9.  Impact of Sonoclot hemostasis analysis after cardiopulmonary bypass on postoperative hemorrhage in cardiac surgery.

Authors:  Tatsuya Yamada; Nobuyuki Katori; Kenichi A Tanaka; Junzo Takeda
Journal:  J Anesth       Date:  2007-05-30       Impact factor: 2.078

Review 10.  Thrombelastography and tromboelastometry in assessing coagulopathy in trauma.

Authors:  Pär I Johansson; Trine Stissing; Louise Bochsen; Sisse R Ostrowski
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2009-09-23       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.